Running wheel access and resulting voluntary exercise alter food intake and reduce body weight.
PVN CRF mRNA expression. NPY mRNA expression was increased in both the ARC and the DMH. To assess a functional role for the increased DMH CRF mRNA expression in the reduced feeding, we examined the ability of intracerebroventricular (ICV) injection of a CRF antagonist to alter the feeding response to running wheel access. Antagonist administration attenuated the feeding reduction and further increased DMH CRF gene expression in rats with running wheel access. These results provide evidence for a critical role for DMH CRF in the effects of exercise on food intake and energy balance.
METHODS
Sprague-Dawley male rats weighing 250-275 g were purchased from Charles River Laboratories, Inc. Rats were individually housed and maintained on a 12: 12-h light-dark cycle (lights on at 6:00 AM) in a temperature-controlled environment (22 o C) with food and water available ad libitum. All procedures were approved by the Institutional Animal Care and Use Committee at the Johns Hopkins University.
Running wheel access, food intake and body weight. In the first experiment, 12 male rats were transferred into running wheel cages containing an automated pellet dispenser controlled by an infrared pellet-sensing photo beam. Pellet dispensers delivered a 45-mg chow pellet (Bio-Serv, Frenchtown, NJ) in response to the removal of the previous pellet. Running wheels were kept in a locked position for the initial 10 days. After 10 days, animals were weight matched and assigned to one of two groups: 6 rats with access to running wheels (indicated as unlocked) and other 6 rats kept in cages with locked running wheel (indicated as locked) for 7 days. All animals had ad libitum access to food and water. Food intake and running wheel activity were computer monitored 24 hours per day (Med Associates, Inc., Georgia, Vermont). Body weights were measured daily. At the end of experiment, all rats were killed between 9:00 and 11:00 AM by decapitation under ether inhalation anesthesia. Brains were removed and rapidly frozen in iso-pentane on dry ice for subsequent analyses of hypothalamic gene expression.
Central injection of CRF antagonist.
In the second experiment, rats were kept in locked running wheel cages and unilaterally implanted with chronic indwelling lateral ventricular cannulae. Rats were anesthetized with an intramuscular (im) mixture of Ketamine (100 mg/kg) and Xylazine (20 mg/kg) and placed in a stereotaxic device. A 23-gauge stainless-steel guide cannula was implanted 5.0 mm below dura, 1 mm caudal to bregma and 1.3 mm lateral to midline (21). A 30-gauge stainless-steel obturator was inserted into the cannula to maintain potency. Rats were given penicillin (60,000 units, im) following surgery to prevent postoperative infection. After 1 wk of postoperative recovery, cannula placements were assessed by examining water intake in response to ICV angiotensin administration. Rats were deprived of water for 1 h, injected with ICV 50 ng angiotensin-II in 5 µl saline solution and allowed 30 min access to water in graduated drinking tubes. Water intake of 5 ml greater with angiotensin than following saline vehicle administration was the criterion for correct cannula placement.
Prior to unlocking the running wheels , we determined whether CRF antagonist itself affected food intake or body weight. Twelve rats with correct cannula placements were maintained in running wheels with locked positions, weight matched and assigned to one of 2 groups: one group received ICV vehicle with 2 injections (4.5 µl of saline solution per each) and other one received 2 injections of 15 nmol CRF antagonist -helical-CRF [9-41] ( -hCRF, SIGMA) dissolved in saline in 4.5 µl. The first injection was given at 5:00 PM (one hour before light off) and the second injection was given at 9:00 AM the next morning. This dose of CRF antagonist has previously been demonstrated to prevent forced exercise-induced anorexia (24). ICV injections were made with a Gilmont microliter syringe attached to polyethylene tubing and a 30-gauge stainless-steel injector. The tip of the injector extended 1.5 mm past the tip of the guide cannula. After injections, food intake was computer monitored 24 hours per day and body weight was recorded daily. Meal parameters were analyzed by using the Tongue Twister V 1.42 software (Dr. T. A. Houpt, Florida State University, Tallahassee, FL). A meal was defined as the consumption of at least 5 pellets preceded and followed by at least 10 min of no feeding. Meal size was defined as the number of pellets delivered during a meal. This monitoring period lasted 7 days. On day 8, rats were given a second treatment. Animals were randomly divided into two groups and received three 4.5 µl injections of either vehicle or CRF antagonist (15 nmol -hCRF) at 5:00 PM on the first day, and at 9:00 AM and 5:00 PM on the following day. After the first injection at 5:00 PM, running wheels were immediately unlocked. Food intake and running wheel activity were monitored for an additional 7 day period. Body weights were recorded daily. Meal patterns were analyzed as described above. Since we noted that the effects of running wheel access on food intake and meal pattern mainly occurred in first 4 days, we only present data for this period. Data from these animals were compared with data from a third group (n = 6) kept in locked running wheel cages and receiving vehicle injections.
We cannulated an additional 16 rats for examining the effect of CRF antagonist treatment on hypothalamic CRF and NPY mRNA expression. Cannulated placements were assessed and rats were habituated as described above. Rats were weight matched and assigned to one of 4 groups: 4 vehicle treated sedentary rats, 4 vehicle-treated rats with access to running wheels, 4 -hCRF-treated sedentary rats and 4 -hCRF-treated rats with access to running wheels. ICV injections were conducted as described above. Following the first injection at 5:00 PM, sedentary group of rats remained sedentary but running wheel group of rats were immediately allowed to access to running wheels. All animals had ad libitum access to pellets and water until the end of experiments. Forty-two hours after the first injection, all rats were killed at 11:00AM by decapitation under ether inhalation anesthesia. As described above, brains were harvested for subsequent analyses of hypothalamic gene expression.
Cryosections. Coronal sections (14 µm) were cut via a cryostat, mounted on superfrost/plus slides (Fisher Scientific) as a series of 6 series (section 1: slide 1, section 2: slide 2 etc., section 7: slide 1 etc.), fixed with 4% paraformaldehyde and stored at -70 o C for later in situ hybridization determination.
One slide from each series was stained with cresyl violet acetate and used for the selection of sections for the following in situ hybridization. Sections for NPY and DMH CRF mRNA were selected at the region of 3.1-3.5 mm caudal to bregma and for PVN CRF at the region of 1.8-2.1 mm caudal to bregma (21).
Three-six sections per brain were selected and anatomically matched among animals for each in situ hybridization determination. radioactivity data was calculated as the product of hybridization area x density (background density was subtracted). Data for each animal was an average of data generated from 3-6 sections. Data from each group were normalized to vehicle-treated sedentary rats as 100 %, and all data were presented as mean + SEM.
Data analyses. Food intake and body weight gain in the first experiment were analyzed by using two way mixed model ANOVA for the factors of running wheel access and time. For the second experiment, we began by assessing the effect of CRF antagonist treatment on baseline food intake and body weight using a mixed model ANOVA for the factors of treatment and time. Having shown that this dose of CRF antagonist did not affect baseline intake, we then assessed the effects of CRF antagonist on running wheel induced alterations in food intake, meal size, meal number and body weight gain using two way mixed model ANOVA for the factors of treatment (antagonist and/or running wheel access) and time. In situ hybridization data were analyzed by student t test in experiment 1 and by two-way ANOVA for the factors of antagonist treatment and running wheel access in the third experiment. Running activity data were assessed by one way ANOVA for the first experiment and two-way ANOVA for the second experiment. Data were further analyzed by using pairwise multiple Fisher LCD comparisons. p < 0.05 was interpreted as a significant difference.
RESULTS
Effects of running wheel access. During the 7-day period of access to running wheels, rats had running activities at a range from 1500 to 2100 revolutions/d (1.5-2.1 km/d) (Fig. 1A) . Analysis of variance (ANOVA) demonstrated that running wheel access and resulting increased activity significantly decreased food intake and body weight gain ( Fig. 1B and C ). There were significant running wheel access by measurement time interactions for food intake [F(7,70) = 4.440, P < 0.001] and body weight gain [F(7,70) = 10.158, P < 0.001]. Rats with access to running wheels voluntarily decreased food intake by 48% on day 1 and by 30-35% during the day 2-5 period compared with sedentary rats, and the food intake of exercising rats increased on days 6 and 7 to the point that it was no longer significantly suppressed (Fig. 1B) . Rats with access to running wheels did not gain body weight during the first 3 days, and gained body weight more slowly than sedentary controls over the following days (P < 0.001, Fig. 1C ). The in situ hybridization determination revealed that CRF mRNA levels were significantly elevated in the DMH in exercised rats relative to sedentary controls (P < 0.05), but did not differ in the PVN (P > 0.05) by the end of 7-day running wheel access ( Fig. 2) . Running wheel access-induced elevation of DMH CRF gene expression was mainly localized in the dorsal part of the DMH (Fig. 3) .
Both Arc and DMH NPY mRNA levels were significantly increased in response to 7 days of running wheel access ( Fig. 2 and 3) . Although running wheel access affected food intake, body weight gain and mRNA levels of DMH CRF, Arc and DMH NPY, there were no signiciant correlations between levels of running wheel access and food intake, running wheel access and body weight loss or running wheel access and gene expression (P > 0.05).
Effects of ICV CRF antagonist injection on food intake and meal patterns in exercising rats.
Prior to access to running wheels, ICV injection of a CRF antagonist -hCRF did not affect food intake hCRF injection on food intake were mainly due to effects on the size of meals. While running wheel access decreased meal sizes on days 3 and 4, ICV -hCRF administration prevent the significant effect of running wheel access (Fig. 4B) . However, ICV -hCRF injection did not prevent exercise-induced decreases in meal frequency (Fig. 4C) .
Effects of ICV -hCRF injection on body weight and running wheel activity in exercising rats.
Similarly, ICV injection of a CRF antagonist did not affect body weight of sedentary rats [F(1,36) = 0.127, P > 0.05]. Running wheel access resulted in body weight loss, and this weight loss was attenuated by ICV -hCRF injection (Fig. 5A ). ANOVA revealed a significant treatment by measurement time interaction [F(8,64) = 8.100, P < 0.001]. Fisher LSD comparisons revealed that body weight was significantly reduced when rats had access to running wheels, and ICV injection of CRF antagonisthCRF attenuated this reduction on day 3 of running wheels access (Fig. 5A) . Moreover, although running activity was increased by 79 % on the initial day of access to running wheels in rats with -hCRF treatment relative to vehicle treated exercising rats, there was no main effect of ICV -hCRF injection [F(1,36) = 1.848, P = 0.207]. Thus, vehicle and -hCRF treated rats had similar activity on the following days (Fig. 5B) .
Effects of ICV -hCRF injection on CRF and NPY mRNA levels in exercising rats. Although
CRF mRNA levels in the PVN wer not affected by 42 hours of running wheel access, CRF mRNA expression was significantly elevated in the DMH in rats with access to running wheels relative to sedentary rats (Fig. 6) . Two-way ANOVA revealed a significant main effect of running wheel access on DMH CRF mRNA levels [F(1,11) = 12.029, P = 0.0053] but not on PVN CRF mRNA expression [F(1,11) = 0.09, P = 0.7694]. Post-hoc comparisons demonstrated that DMH CRF mRNA levels were significantly elevated in vehicle-treated exercising rats as compared with vehicle-treated sedentary rats, and this elevation was further increased in ICV -hCRF treated exercising rats (from 60% to 112% elevation relative to vehicle-treated sedentary controls) (Fig. 6 ). Forty-two hours of running wheel access did not produce significant changes in Arc NPY mRNA levels, and these levels were not affected by ICV CRF antagonist injection (Fig. 6) . Similarly, in response to 42-hour of running wheel access, DMH NPY mRNA expression was not altered, and ICV -hCRF injection did not affect levels of DMH NPY mRNA expression (Fig. 6 ).
DISCUSSION
The current results demonstrate that running wheel access results in significant decreases in food intake and body weight. This finding is consistent with previous reports showing that food intake is reduced in rats with access to running wheels over a 7-10 day period (16, 18, 19) . Furthermore, we demonstrate that voluntary exercise reduced both meal size and meal frequency. In response to voluntary exercise, we observed that CRF mRNA expression is significantly elevated in the DMH, but not in the PVN. NPY mRNA expression was increased in both arcaute nucleus and the DMH following 7 days of Krahn and colleagues have demonstrated that CRF acts in the PVN to induce not only anorexia, but also to increase locomotion and grooming (14). Koob and colleagues have reported that direct injections of CRF into the amygdala produce anxiety-like behaviors and microinjection of a CRF antagonist into the CeA produces anti-stress effects (13). However, a role for these structures in CRF mediated exerciseinduced anorexia has not been demonstrated. Thus, lesions of either the PVN or the CeA do not prevent the anorectic effect of forced exercise in male rats (5, 23). The present data demonstrating no alterations in PVN CRF mRNA expression during the period in which exercise results in decreased food intake provides additional evidence suggesting that PVN CRF may not serve as a signal to mediate the feeding inhibitory effects of exercise. In contrast, the finding that CRF mRNA expression is significantly elevated in the DMH in response to voluntary exercise and further increased in exercising rats with administration of a CRF antagonist suggest a role for DMH CRF in the mediation of exercise-induced feeding inhibitory effects.
In the current study, we did not find any alterations in NPY mRNA expression in the Arc and the DMH in rats with 42 hours of exercise at a time exercised rats had significantly decreased food intake.
However, we observed that NPY mRNA expression was increased in both the arcuate nucleus and the DMH in rats having a 7-day period of running wheel access. This elevated NPY mRNA expression and presumed release is consistent with previous results showing that Arc and DMH NPY concentration were increased in exercised rats (17). At the time of these increases in NPY mRNA expression, we observed that exercised rats had recovered food intake to the levels close to what sedentary rats consumed. These data suggested that although DMH CRF expression is higher in 7 days of running wheel access than that Despite the findings that voluntary exercise alters food intake, body weight and DMH CRF gene expression, we did not find any correlations between levels of running activity and food intake, running activity and body weight, or running activity and DMH CRF mRNA levels. Moreover, while ICV CRF antagonist treatment attenuated exercise-induced anorexia and body weight loss and resulted in further increases in DMH CRF gene expression, CRF antagonist did not affect the degree of running activity.
presence of rather than the degree of exercise. This lack of correlation is similar to recent findings of Levin and colleagues examining the effects of exercise on food intake, body weight and hypothalamic gene expression in obesity prone rats (15).
In summary, the present results demonstrate that voluntary exercise results in a temporary period of decreased food intake and body weight. These inhibitory effects of voluntary exercise on food intake and body weight appear to be mediated, at least in part, via increases in DMH CRF gene expression.
Elevations of Arc and DMH NPY gene expression in response to 7 days of running wheel access may represent a compensatory response to the increased energy demands resulting from exercise.
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Richard D and Rivest S. Legends Figure 1 . Effects of running wheel access on food intake and body weight. Given access to running wheels, rats had activities ranging from 1500 to 2100 revolutions/d (Fig. 1A) . Running wheel access resulted in decreased food intake (Fig. 1B) and body weight (Fig. 1C) . Values are means + SEM. n = 6/group. *p < 0.05 compared to rats with locked running wheels. 
